Design by Nature: Emerging Applications of Native Liver Extracellular Matrix for Cholangiocyte Organoid-Based Regenerative Medicine

Overview

Journal Bioengineering (Basel)

Date 2022 Mar 24

PMID 35324799

Authors

Jorke Willemse

Luc J W van der Laan

Jeroen De Jonge

Monique M A Verstegen

Affiliations

Soon will be listed here.

Abstract

Organoid technology holds great promise for regenerative medicine. Recent studies show feasibility for bile duct tissue repair in humans by successfully transplanting cholangiocyte organoids in liver grafts during perfusion. Large-scale expansion of cholangiocytes is essential for extending these regenerative medicine applications. Human cholangiocyte organoids have a high and stable proliferation capacity, making them an attractive source of cholangiocytes. Commercially available basement membrane extract (BME) is used to expand the organoids. BME allows the cells to self-organize into 3D structures and stimulates cell proliferation. However, the use of BME is limiting the clinical applications of the organoids. There is a need for alternative tissue-specific and clinically relevant culture substrates capable of supporting organoid proliferation. Hydrogels prepared from decellularized and solubilized native livers are an attractive alternative for BME. These hydrogels can be used for the culture and expansion of cholangiocyte organoids in a clinically relevant manner. Moreover, the liver-derived hydrogels retain tissue-specific aspects of the extracellular microenvironment. They are composed of a complex mixture of bioactive and biodegradable extracellular matrix (ECM) components and can support the growth of various hepatobiliary cells. In this review, we provide an overview of the clinical potential of native liver ECM-based hydrogels for applications with human cholangiocyte organoids. We discuss the current limitations of BME for the clinical applications of organoids and how native ECM hydrogels can potentially overcome these problems in an effort to unlock the full regenerative clinical potential of the organoids.

Citing Articles

Clinical applications of human organoids.

Verstegen M, Coppes R, Beghin A, De Coppi P, Gerli M, de Graeff N Nat Med. 2025; 31(2):409-421.

PMID: 39901045 DOI: 10.1038/s41591-024-03489-3.

Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.

Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F Biomolecules. 2025; 15(1).

PMID: 39858515 PMC: 11763965. DOI: 10.3390/biom15010121.

Label-Free Proteomics of Severe Acute Hepatitis of Unknown Origin in Children by High-Resolution Mass Spectrometry.

de Farias J, de Lima Vitorino M, Martins Esteves F, Fonseca Lima E, da Silva R, de Lima Filho J ACS Omega. 2025; 9(51):50685-50694.

PMID: 39741806 PMC: 11684528. DOI: 10.1021/acsomega.4c08745.

Decellularized extracellular matrix for organoid and engineered organ culture.

Guo X, Liu B, Zhang Y, Cheong S, Xu T, Lu F J Tissue Eng. 2024; 15:20417314241300386.

PMID: 39611117 PMC: 11603474. DOI: 10.1177/20417314241300386.

Enhancing organoid culture: harnessing the potential of decellularized extracellular matrix hydrogels for mimicking microenvironments.

Li C, An N, Song Q, Hu Y, Yin W, Wang Q J Biomed Sci. 2024; 31(1):96.

PMID: 39334251 PMC: 11429032. DOI: 10.1186/s12929-024-01086-7.

References

Kobayashi S, Ito E, Honma R, Nojima Y, Shibuya M, Watanabe S . Dynamic regulation of gene expression by the Flt-1 kinase and Matrigel in endothelial tubulogenesis. Genomics. 2004; 84(1):185-92. DOI: 10.1016/j.ygeno.2004.02.009. View

Mazza G, Rombouts K, Rennie Hall A, Urbani L, Luong T, Al-Akkad W . Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep. 2015; 5:13079. PMC: 4528226. DOI: 10.1038/srep13079. View

Tottey S, Johnson S, Crapo P, Reing J, Zhang L, Jiang H . The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials. 2010; 32(1):128-36. PMC: 2987535. DOI: 10.1016/j.biomaterials.2010.09.006. View

White L, Taylor A, Faulk D, Keane T, Saldin L, Reing J . The impact of detergents on the tissue decellularization process: A ToF-SIMS study. Acta Biomater. 2016; 50:207-219. PMC: 5592694. DOI: 10.1016/j.actbio.2016.12.033. View

Willemse J, Verstegen M, Vermeulen A, Schurink I, Roest H, van der Laan L . Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion. Mater Sci Eng C Mater Biol Appl. 2020; 108:110200. DOI: 10.1016/j.msec.2019.110200. View

Nakamura S, Ijima H . Solubilized matrix derived from decellularized liver as a growth factor-immobilizable scaffold for hepatocyte culture. J Biosci Bioeng. 2013; 116(6):746-53. DOI: 10.1016/j.jbiosc.2013.05.031. View

Lin P, Chan W, Badylak S, Bhatia S . Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng. 2004; 10(7-8):1046-53. DOI: 10.1089/ten.2004.10.1046. View

Gazia C, Tamburrini R, Asthana A, Chaimov D, Muir S, Marino D . Extracellular matrix-based hydrogels obtained from human tissues: a work still in progress. Curr Opin Organ Transplant. 2019; 24(5):604-612. DOI: 10.1097/MOT.0000000000000691. View

Huch M, Dorrell C, Boj S, van Es J, Li V, van de Wetering M . In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature. 2013; 494(7436):247-50. PMC: 3634804. DOI: 10.1038/nature11826. View

10.

Schneeberger K, Sanchez-Romero N, Ye S, van Steenbeek F, Oosterhoff L, Palacin I . Large-Scale Production of LGR5-Positive Bipotential Human Liver Stem Cells. Hepatology. 2019; 72(1):257-270. PMC: 7496924. DOI: 10.1002/hep.31037. View

11.

Ren H, Shi X, Tao L, Xiao J, Han B, Zhang Y . Evaluation of two decellularization methods in the development of a whole-organ decellularized rat liver scaffold. Liver Int. 2013; 33(3):448-58. DOI: 10.1111/liv.12088. View

12.

Williams C, Sullivan K, Black 3rd L . Partially Digested Adult Cardiac Extracellular Matrix Promotes Cardiomyocyte Proliferation In Vitro. Adv Healthc Mater. 2015; 4(10):1545-54. PMC: 4504755. DOI: 10.1002/adhm.201500035. View

13.

Desai S, Tung J, Zhou V, Grenert J, Malato Y, Rezvani M . Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha. Hepatology. 2016; 64(1):261-75. PMC: 5224931. DOI: 10.1002/hep.28450. View

14.

Benyon R, Arthur M . Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis. 2001; 21(3):373-84. DOI: 10.1055/s-2001-17552. View

15.

Loneker A, Faulk D, Hussey G, DAmore A, Badylak S . Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in-vitro. J Biomed Mater Res A. 2015; 104(4):957-65. DOI: 10.1002/jbm.a.35636. View

16.

Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen M . Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2014; 160(1-2):299-312. PMC: 4313365. DOI: 10.1016/j.cell.2014.11.050. View

17.

Lee J, Shin J, Park H, Kim Y, Kim B, Oh J . Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering. Biomacromolecules. 2013; 15(1):206-18. DOI: 10.1021/bm4015039. View

18.

Verstegen M, Willemse J, van den Hoek S, Kremers G, Luider T, van Huizen N . Decellularization of Whole Human Liver Grafts Using Controlled Perfusion for Transplantable Organ Bioscaffolds. Stem Cells Dev. 2017; 26(18):1304-1315. DOI: 10.1089/scd.2017.0095. View

19.

Fernandez-Perez J, Ahearne M . The impact of decellularization methods on extracellular matrix derived hydrogels. Sci Rep. 2019; 9(1):14933. PMC: 6797749. DOI: 10.1038/s41598-019-49575-2. View

20.

Soroka C, Assis D, Alrabadi L, Roberts S, Cusack L, Jaffe A . Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile. Hepatology. 2018; 70(3):871-882. DOI: 10.1002/hep.30470. View